Reactivación de hepatitis B en paciente con hepatitis crónica C tratado con antivirales de acción directa

Antón, M Dolores; Polanco, Ana; Ferrando, Inmaculada; Latorre, Patricia; Pascual, Andrea; Moreno Osset, Eduardo.
Gastroenterol. hepatol. (Ed. impr.) ; 41(5): 317-319, mayo 2018.
Artículo en Español | IBECS (España) | ID: ibc-180606

Documentos relacionados

  1. Omic approaches to decipher the molecular mechanisms of fibrosis, and design new anti-fibrotic strategies.
  2. Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines.
  3. Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE.
  4. The current landscape of antifibrotic therapy across different organs: A systematic approach.
  5. Secukinumab for psoriasis in a patient with hepatitis B.
  6. Response to letter to the editor "Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy".
  7. Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy.
  8. Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies-A population-based study.
  9. Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study.
  10. A Very Young Adult Female Patient with Hepatitis B Flare: A Case Report.